Mutual of America Capital Management LLC Trims Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Mutual of America Capital Management LLC lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,523 shares of the company’s stock after selling 800 shares during the period. Mutual of America Capital Management LLC’s holdings in Henry Schein were worth $1,327,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Xponance Inc. increased its stake in Henry Schein by 2.1% during the third quarter. Xponance Inc. now owns 21,839 shares of the company’s stock worth $1,622,000 after acquiring an additional 443 shares during the last quarter. Everett Harris & Co. CA raised its holdings in Henry Schein by 29.1% in the 4th quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock valued at $7,925,000 after buying an additional 23,622 shares during the period. Caxton Associates LP lifted its position in Henry Schein by 80.8% in the third quarter. Caxton Associates LP now owns 18,991 shares of the company’s stock valued at $1,410,000 after buying an additional 8,486 shares during the last quarter. American Century Companies Inc. boosted its stake in Henry Schein by 7.3% during the third quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock worth $350,392,000 after buying an additional 322,649 shares during the period. Finally, Stifel Financial Corp increased its position in shares of Henry Schein by 4.9% during the third quarter. Stifel Financial Corp now owns 1,006,215 shares of the company’s stock valued at $74,712,000 after acquiring an additional 46,894 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on HSIC shares. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Piper Sandler upped their price objective on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a report on Monday, February 26th. Jefferies Financial Group boosted their target price on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. SVB Leerink assumed coverage on Henry Schein in a report on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective on the stock. Finally, Evercore ISI upped their price target on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research report on Wednesday, February 28th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $81.09.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

HSIC stock opened at $72.04 on Tuesday. The company has a market capitalization of $9.26 billion, a price-to-earnings ratio of 22.87, a P/E/G ratio of 1.76 and a beta of 0.87. The firm has a 50 day moving average of $74.30 and a two-hundred day moving average of $72.44. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $85.39.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by ($0.04). The company had revenue of $3.02 billion for the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. Henry Schein’s quarterly revenue was down 10.5% on a year-over-year basis. During the same quarter last year, the business earned $1.21 earnings per share. As a group, equities analysts anticipate that Henry Schein, Inc. will post 5.07 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.